_id

691052aaccc777a4e85d54db

Ticker

COEP

Name

Coeptis Therapeutics Inc

Exchange

NASDAQ

Address

105 Bradford Road, Wexford, PA, United States, 15090

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://coeptistx.com

Description

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy technology. Its product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological and solid tumors. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

Last Close

15.13

Volume

40866

Current Price

15.09

Change

-0.2643754130865891

Last Updated

2025-11-29T11:43:35.451Z

Image

data:image/webp;base64,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

Ipo Date

2020-12-17T00:00:00.000Z

Market Cap

68207480

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

3

Target Price

3

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

237441

Cost Of Revenue

45155

Gross Profit

192286

Operating Expenses

2669314

Operating Income

-2477028

Interest Expense

62610

Pretax Income

-2898763

Net Income

-159360

Eps

-0.033584196207910956

Dividends Per Share

-

Shares Outstanding

4820317

Income Tax Expense

-2739403

EBITDA

-2530388

Operating Margin

-1043.2183152867449

Total Other Income Expense Net

-421735

Cash

4908487

Short Term Investments

421698

Receivables

86041

Inventories

-

Total Current Assets

5990862

Property Plant Equipment

39124

Total Assets

16282008

Payables

783103

Short Term Debt

129865

Long Term Debt

150000

Total Liabilities

3264864

Equity

12465950

Depreciation

305765

Change In Working Capital

-579880

Cash From Operations

-2152217

Capital Expenditures

3

Cash From Investing

-

Cash From Financing

5063978

Net Change In Cash

2911761

PE

-

PB

5.759143632855899

ROE

-1.2783622587929522

ROA

-0.978749058469938

FCF

-2152220

Fcf Percent

-9.064230693098496

Piotroski FScore

0

Health Score

29

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

3.5

Growth Investing Score

2

Momentum Investing Score

4

Net Net Investing Score

1

Quality Investing Score

3

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

237441

Quarters > 0 > income Statement > cost Of Revenue

45155

Quarters > 0 > income Statement > gross Profit

192286

Quarters > 0 > income Statement > operating Expenses

2669314

Quarters > 0 > income Statement > operating Income

-2477028

Quarters > 0 > income Statement > interest Expense

62610

Quarters > 0 > income Statement > pretax Income

-2898763

Quarters > 0 > income Statement > net Income

-159360

Quarters > 0 > income Statement > eps

-0.033584196207910956

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

4745089

Quarters > 0 > income Statement > income Tax Expense

-2739403

Quarters > 0 > income Statement > EBITDA

-2530388

Quarters > 0 > income Statement > operating Margin

-1043.2183152867449

Quarters > 0 > income Statement > total Other Income Expense Net

-421735

Quarters > 0 > balance Sheet > cash

4908487

Quarters > 0 > balance Sheet > short Term Investments

421698

Quarters > 0 > balance Sheet > receivables

86041

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5990862

Quarters > 0 > balance Sheet > property Plant Equipment

39124

Quarters > 0 > balance Sheet > total Assets

16282008

Quarters > 0 > balance Sheet > payables

783103

Quarters > 0 > balance Sheet > short Term Debt

129865

Quarters > 0 > balance Sheet > long Term Debt

150000

Quarters > 0 > balance Sheet > total Liabilities

3264864

Quarters > 0 > balance Sheet > equity

12465950

Quarters > 0 > cash Flow > net Income

-2739403

Quarters > 0 > cash Flow > depreciation

305765

Quarters > 0 > cash Flow > change In Working Capital

-579880

Quarters > 0 > cash Flow > cash From Operations

-2152217

Quarters > 0 > cash Flow > capital Expenditures

3

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

5063978

Quarters > 0 > cash Flow > net Change In Cash

2911761

Quarters > 0 > ratios > PE

-0.033584196207910956

Quarters > 0 > ratios > PB

5.759143632855899

Quarters > 0 > ratios > ROE

-1.2783622587929522

Quarters > 0 > ratios > ROA

-0.978749058469938

Quarters > 0 > ratios > FCF

-2152220

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-9.064230693098496

Quarters > 0 > health Score

29

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

200681

Quarters > 1 > income Statement > cost Of Revenue

45157

Quarters > 1 > income Statement > gross Profit

155524

Quarters > 1 > income Statement > operating Expenses

4676738

Quarters > 1 > income Statement > operating Income

-4521214

Quarters > 1 > income Statement > interest Expense

67788

Quarters > 1 > income Statement > pretax Income

-4334586

Quarters > 1 > income Statement > net Income

-3534595

Quarters > 1 > income Statement > eps

-0.9535447738545023

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

3706795

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-3961271

Quarters > 1 > income Statement > operating Margin

-2252.9357537584524

Quarters > 1 > income Statement > total Other Income Expense Net

186628

Quarters > 1 > balance Sheet > cash

1996726

Quarters > 1 > balance Sheet > short Term Investments

990566

Quarters > 1 > balance Sheet > receivables

30000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

3694935

Quarters > 1 > balance Sheet > property Plant Equipment

49731

Quarters > 1 > balance Sheet > total Assets

12191479

Quarters > 1 > balance Sheet > payables

1028826

Quarters > 1 > balance Sheet > short Term Debt

1163745

Quarters > 1 > balance Sheet > long Term Debt

150000

Quarters > 1 > balance Sheet > total Liabilities

5111349

Quarters > 1 > balance Sheet > equity

6095830

Quarters > 1 > cash Flow > net Income

-4334586

Quarters > 1 > cash Flow > depreciation

305527

Quarters > 1 > cash Flow > change In Working Capital

-769219

Quarters > 1 > cash Flow > cash From Operations

-2396742

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

125100

Quarters > 1 > cash Flow > net Change In Cash

-2271642

Quarters > 1 > ratios > PE

-0.9535447738545023

Quarters > 1 > ratios > PB

9.200356366565341

Quarters > 1 > ratios > ROE

-57.98381844638057

Quarters > 1 > ratios > ROA

-28.992339649684833

Quarters > 1 > ratios > FCF

-2396742

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-11.943043935399963

Quarters > 1 > health Score

23

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

62874

Quarters > 2 > income Statement > cost Of Revenue

45156

Quarters > 2 > income Statement > gross Profit

17718

Quarters > 2 > income Statement > operating Expenses

4074702

Quarters > 2 > income Statement > operating Income

-4056984

Quarters > 2 > income Statement > interest Expense

71491

Quarters > 2 > income Statement > pretax Income

-3420941

Quarters > 2 > income Statement > net Income

-3057730

Quarters > 2 > income Statement > eps

-0.9950069539490426

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

3073074

Quarters > 2 > income Statement > income Tax Expense

-363211

Quarters > 2 > income Statement > EBITDA

-3044157

Quarters > 2 > income Statement > operating Margin

-6452.562267391927

Quarters > 2 > income Statement > total Other Income Expense Net

636043

Quarters > 2 > balance Sheet > cash

4268368

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

4650996

Quarters > 2 > balance Sheet > property Plant Equipment

60102

Quarters > 2 > balance Sheet > total Assets

13453067

Quarters > 2 > balance Sheet > payables

1120657

Quarters > 2 > balance Sheet > short Term Debt

1871435

Quarters > 2 > balance Sheet > long Term Debt

150000

Quarters > 2 > balance Sheet > total Liabilities

5990153

Quarters > 2 > balance Sheet > equity

6478614

Quarters > 2 > cash Flow > net Income

-3420941

Quarters > 2 > cash Flow > depreciation

305297

Quarters > 2 > cash Flow > change In Working Capital

-220755

Quarters > 2 > cash Flow > cash From Operations

-2366167

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

6101650

Quarters > 2 > cash Flow > net Change In Cash

3735483

Quarters > 2 > ratios > PE

-0.9950069539490426

Quarters > 2 > ratios > PB

7.1767834323822965

Quarters > 2 > ratios > ROE

-47.19728633315706

Quarters > 2 > ratios > ROA

-22.728869186483646

Quarters > 2 > ratios > FCF

-2366167

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-37.63347329579795

Quarters > 2 > health Score

23

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1863452

Quarters > 3 > income Statement > cost Of Revenue

259982

Quarters > 3 > income Statement > gross Profit

-259982

Quarters > 3 > income Statement > operating Expenses

1902232

Quarters > 3 > income Statement > operating Income

-2162214

Quarters > 3 > income Statement > interest Expense

78629

Quarters > 3 > income Statement > pretax Income

-3011765

Quarters > 3 > income Statement > net Income

-3011765

Quarters > 3 > income Statement > eps

-1.5648467063173925

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

1924639

Quarters > 3 > income Statement > income Tax Expense

-1063809

Quarters > 3 > income Statement > EBITDA

-2673157

Quarters > 3 > income Statement > operating Margin

-116.03271777325092

Quarters > 3 > income Statement > total Other Income Expense Net

-849551

Quarters > 3 > balance Sheet > cash

532885

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1051292

Quarters > 3 > balance Sheet > property Plant Equipment

59783

Quarters > 3 > balance Sheet > total Assets

8908660

Quarters > 3 > balance Sheet > payables

1269763

Quarters > 3 > balance Sheet > short Term Debt

1230178

Quarters > 3 > balance Sheet > long Term Debt

150000

Quarters > 3 > balance Sheet > total Liabilities

5041434

Quarters > 3 > balance Sheet > equity

3185164

Quarters > 3 > cash Flow > net Income

-3011765

Quarters > 3 > cash Flow > depreciation

259982

Quarters > 3 > cash Flow > change In Working Capital

-44293

Quarters > 3 > cash Flow > cash From Operations

-1436538

Quarters > 3 > cash Flow > capital Expenditures

1

Quarters > 3 > cash Flow > cash From Investing

100000

Quarters > 3 > cash Flow > cash From Financing

731971

Quarters > 3 > cash Flow > net Change In Cash

-604568

Quarters > 3 > ratios > PE

-1.5648467063173925

Quarters > 3 > ratios > PB

9.14231985229018

Quarters > 3 > ratios > ROE

-94.55604169832385

Quarters > 3 > ratios > ROA

-33.80716067287336

Quarters > 3 > ratios > FCF

-1436539

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.7709020677752901

Quarters > 3 > health Score

17

Valuation > metrics > PE

-0.033584196207910956

Valuation > metrics > PB

5.759143632855899

Valuation > final Score

22.40856367144101

Valuation > verdict

92.0% Overvalued

Profitability > metrics > ROE

-1.2783622587929522

Profitability > metrics > ROA

-2.6600512580660345

Profitability > metrics > Net Margin

-0.6711562030146436

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.2619025425258404

Risk > metrics > Interest Coverage

-39.56281744130331

Risk > final Score

-98

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.5619627413009

Liquidity > metrics > Quick Ratio

6.5619627413009

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-219

Prev Risks > 1

-179

Prev Risks > 2

-80

Prev Liquidities > 0

92

Prev Liquidities > 1

89

Prev Liquidities > 2

31

Updated At

2025-12-16T13:23:27.522Z